Popular on TelAve
- L.A. County Board of Supervisors Recognizes Amapola Market for Outstanding Community Philanthropy
- Jones Sign Unveils Jones Vision LED Displays
- Le trio français de Punk-Metal Psychédélique Joe La Truite signe un contrat de management international
- Speranza Dental Implant Center's New Website Launch!
- Purfresh Clean launches its new "SPACE" product - An innovative technology restaurants are using to get rid of their rat and mice problems
- Century Fasteners Corp. Receives Accreditation to AS9120B Quality Management Systems
- Big News!! Best Sac Homes Group Partners with LPT Realty
- LIB Empowers Uzbekistan's Automotive Industry: A New Era of Quality Assurance
- Axiros' Founder Gunther Klessinger Takes on CTO Role to Lead Axiros into a New Era of Technology
- New Release: Kannazuki, Vol. 1: The Beast Of Akune Shakes Up the Fantasy Genre!
Similar on TelAve
- Live Good: A Journey of Courage, Education and Purpose
- Coupert Achieves Remarkable Growth During Black Friday, Redefining the Shopping Experience
- Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
- Nebul Collaboration to Employ NVIDIA Cutting Edge AI Tech with Established GEDi CUBE Paradigm Shift for Early Disease Detection: Stock Symbol: RENB
- Industry-Changing Multi-Benefit Service Platform for Technology Systems & AI Smart Devices Drives; 218% Revenue Growth for Tekumo: Stock Symbol: TKMO
- Twin Brothers Debut "Tuning to the Soil-ed Seed Vibrations For Our Collective Health" In 3 Formats (Paperback, Hardcover & EPUB) On 19 Dec. 2024
- NaturismRE: Advocating for Health, Freedom, and a Harmonious Future Rooted in Nature
- Webinar Announcement: Navigating the New Investment Adviser AML Mandate: What Steps Should Investment Advisers Be Taking Now?
- Peachtree Immediate Care Opens Two New Locations in December
- Kaplan Morrell's Britton Morrell Named One of Denver's Top Lawyers of 2024 by 5280 Magazine
TCB Capital Advisors Congratulates Altoida & Gregor Diagnostics on 2024 Merit Awards Recognition
TelAve News/10845519
THE WOODLANDS, Texas - TelAve -- TCB Capital Advisors proudly announces two of its partners, Altoida Inc. and Gregor Diagnostics Inc., have been recognized by the 2024 Merit Awards for Healthcare. These awards celebrate companies demonstrating groundbreaking advancements in medical technology, healthcare innovation, and patient care.
Altoida received the Gold Award for "Best Use of Artificial Intelligence," a testament to its leadership in digital health and AI applications that enhance the early detection of neurodegenerative diseases, including Alzheimer's. Altoida's pioneering NeuroMarker Platform utilizes a tablet-based application powered by augmented reality (AR) and artificial intelligence/machine learning (AI/ML) designed to deliver rapid and objective multi-modal assessment of cognitive health and function. The platform aim's to equip frontline clinicians with clinical insights to enable earlier detection, personalized care and to lead to improved patient outcomes.
Gregor Diagnostics earned the Bronze Award in the "Innovations" category, underscoring the company's achievements in developing revolutionary diagnostic solutions. Gregor Diagnostics is dedicated to pioneering advancements in prostate cancer detection, aiming to deliver earlier and more precise diagnostics for better patient outcomes.
More on TelAve News
"It's truly an honor to see Altoida and Gregor Diagnostics acknowledged for their groundbreaking work," Sam Libby, President and Managing Director at TCB Capital Advisors, expressed. "The Merit Awards spotlight innovators who are reshaping the future of healthcare, and we at TCB are so proud to support such visionary leaders who are driving remarkable advancements in patient care and medical science."
The 2024 Merit Awards for Healthcare highlights outstanding achievements across various healthcare sectors, selecting winners based on their significant impact on improving healthcare delivery and innovation.
For more information please visit Altoida and Gregor Diagnostics. To learn more about TCB Capital Advisors, visit TCB Capital Advisors.
About Altoida
Altoida is the leader in developing digital biomarkers for neurological conditions, including Alzheimer's disease. Its innovative Altoida Digital NeuroMarker Platform leverages artificial intelligence and augmented reality (AR) to deliver objective and precise assessments of cognitive health. The platform uses a tablet-based app that offers a quick, self-administered series of motor, speech, and AR tasks, simulating daily activities to evaluate brain health. These tasks measure key cognitive metrics, including micro-movements, processing speed, reaction time, and spatial navigation. Altoida is a privately held, venture-backed diagnostics company with a proprietary platform built on over 20 years of scientific research. Its evidence-based technology has been featured in numerous global pharmaceutical studies and published in prestigious peer-reviewed journals, including Nature Digital Medicine.
More on TelAve News
About Gregor Diagnostics
Gregor Diagnostics Inc. is a molecular diagnostics company developing groundbreaking diagnostics for prostate cancer. Gregor Diagnostics' patient-friendly test is sensitive enough to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. Gregor Diagnostics is making early detection and less invasive identification and management of prostate cancer a reality while decreasing the overdiagnosis and overtreatment of indolent prostate cancer.
About TCB Capital Advisors
TCB Capital Advisors is a boutique investment bank and advisory firm focused on the healthcare and life sciences sectors. The firm specializes in advising clients with their buying, selling, investment, and growth strategies, leveraging decades of combined Wall Street and industry experience. TCB Capital Advisors offers a tailored approach, focusing on transaction advisory, corporate development, revenue growth, and post-transaction integration, working with clients across venture, growth, and middle-market verticals. Founded in 2023 by former members of the healthcare team at Piper Sandler, TCB Capital Advisors is headquartered in Houston, TX with offices/team members based in New York, North Carolina, and Tennessee. Securities are offered through Finalis Securities, LLC (member FINRA/SIPC). TCB Capital Advisors is not a registered broker-dealer, and Finalis Securities, LLC and TCB Capital Advisors are separated, unaffiliated entities. For more information, please visit www.tcbcapitaladvisors.com.
Altoida received the Gold Award for "Best Use of Artificial Intelligence," a testament to its leadership in digital health and AI applications that enhance the early detection of neurodegenerative diseases, including Alzheimer's. Altoida's pioneering NeuroMarker Platform utilizes a tablet-based application powered by augmented reality (AR) and artificial intelligence/machine learning (AI/ML) designed to deliver rapid and objective multi-modal assessment of cognitive health and function. The platform aim's to equip frontline clinicians with clinical insights to enable earlier detection, personalized care and to lead to improved patient outcomes.
Gregor Diagnostics earned the Bronze Award in the "Innovations" category, underscoring the company's achievements in developing revolutionary diagnostic solutions. Gregor Diagnostics is dedicated to pioneering advancements in prostate cancer detection, aiming to deliver earlier and more precise diagnostics for better patient outcomes.
More on TelAve News
- Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
- Wisconsin People's Party backs Amazon unionization amid CEO wealth surge
- Donna Fitzgerald of Georgia Documentary Filmmaker, Entrepreneur, and Veterans Advocate
- Somebody's Husband by Robbi Renee Earns Early Acclaim for Its Powerful Exploration of Love, Loss, and Healing
- Nebul Collaboration to Employ NVIDIA Cutting Edge AI Tech with Established GEDi CUBE Paradigm Shift for Early Disease Detection: Stock Symbol: RENB
"It's truly an honor to see Altoida and Gregor Diagnostics acknowledged for their groundbreaking work," Sam Libby, President and Managing Director at TCB Capital Advisors, expressed. "The Merit Awards spotlight innovators who are reshaping the future of healthcare, and we at TCB are so proud to support such visionary leaders who are driving remarkable advancements in patient care and medical science."
The 2024 Merit Awards for Healthcare highlights outstanding achievements across various healthcare sectors, selecting winners based on their significant impact on improving healthcare delivery and innovation.
For more information please visit Altoida and Gregor Diagnostics. To learn more about TCB Capital Advisors, visit TCB Capital Advisors.
About Altoida
Altoida is the leader in developing digital biomarkers for neurological conditions, including Alzheimer's disease. Its innovative Altoida Digital NeuroMarker Platform leverages artificial intelligence and augmented reality (AR) to deliver objective and precise assessments of cognitive health. The platform uses a tablet-based app that offers a quick, self-administered series of motor, speech, and AR tasks, simulating daily activities to evaluate brain health. These tasks measure key cognitive metrics, including micro-movements, processing speed, reaction time, and spatial navigation. Altoida is a privately held, venture-backed diagnostics company with a proprietary platform built on over 20 years of scientific research. Its evidence-based technology has been featured in numerous global pharmaceutical studies and published in prestigious peer-reviewed journals, including Nature Digital Medicine.
More on TelAve News
- The Curtain Rose on the 2025 Awards Season in Dazzling Style as the Society of Voice Arts and Sciences Celebrated its 11th Annual Voice Arts® Awards
- Industry-Changing Multi-Benefit Service Platform for Technology Systems & AI Smart Devices Drives; 218% Revenue Growth for Tekumo: Stock Symbol: TKMO
- Twin Brothers Debut "Tuning to the Soil-ed Seed Vibrations For Our Collective Health" In 3 Formats (Paperback, Hardcover & EPUB) On 19 Dec. 2024
- NaturismRE: Advocating for Health, Freedom, and a Harmonious Future Rooted in Nature
- Vantiva Announces Plan to Sell its Supply Chain Solutions Division to Funds Managed by Variant Equity
About Gregor Diagnostics
Gregor Diagnostics Inc. is a molecular diagnostics company developing groundbreaking diagnostics for prostate cancer. Gregor Diagnostics' patient-friendly test is sensitive enough to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. Gregor Diagnostics is making early detection and less invasive identification and management of prostate cancer a reality while decreasing the overdiagnosis and overtreatment of indolent prostate cancer.
About TCB Capital Advisors
TCB Capital Advisors is a boutique investment bank and advisory firm focused on the healthcare and life sciences sectors. The firm specializes in advising clients with their buying, selling, investment, and growth strategies, leveraging decades of combined Wall Street and industry experience. TCB Capital Advisors offers a tailored approach, focusing on transaction advisory, corporate development, revenue growth, and post-transaction integration, working with clients across venture, growth, and middle-market verticals. Founded in 2023 by former members of the healthcare team at Piper Sandler, TCB Capital Advisors is headquartered in Houston, TX with offices/team members based in New York, North Carolina, and Tennessee. Securities are offered through Finalis Securities, LLC (member FINRA/SIPC). TCB Capital Advisors is not a registered broker-dealer, and Finalis Securities, LLC and TCB Capital Advisors are separated, unaffiliated entities. For more information, please visit www.tcbcapitaladvisors.com.
Source: TCB Capital Advisors
0 Comments
Latest on TelAve News
- Men at 63 and Their Three Daily Battles
- Disabled Homeless Veteran Bryan Corrigan launches 'TRUMP TEAM TRANSPORT' to empower and revitalize Salt Lake City's economy
- The Ripple Effect Arts Launches Revolutionary Organic Wild Yam Cream Following Viral Success
- Discover a Community of Love and Spiritual Growth: Join Unity of Las Vegas Church Today
- Plan Ahead for a 2025 Florida Keys Vacation and Save 15 Percent with KeysCaribbean's 90-Day Advance Purchase Discount
- Axiros' Founder Gunther Klessinger Takes on CTO Role to Lead Axiros into a New Era of Technology
- Macy Alex Photography Hosts Art Showcase and Fundraiser Benefiting Giving Grace
- ONI KAI NINJUTSU Opens Flagship Martial Arts Dojo in Pollock Pines, CA
- The Shot Heard Around the Business World – And the Heroes of American Business
- CUMIC Listed Among Forbes China Go-International Top 30 Brand
- HoverGrease 2 Kicks Off their Steam Wishlist Page with a Surprise Reveal Trailer
- Work 365 Now Available on Pax8 Marketplace, Empowering MSPs with Enhanced CSP Management
- VerifyTreatment Expands Its Salesforce Functionality with Cyntexa's Expertise
- Events by Dubsdread Offerings Go Beyond Weddings
- Century Fasteners Corp. Receives Accreditation to AS9120B Quality Management Systems
- Material Capital Partners Closes Financing for 170-Unit Build-For-Rent Community in Brunswick, Georgia
- The Computer Works Secures Growth Capital to Expand Fiber Connectivity
- New Release: Kannazuki, Vol. 1: The Beast Of Akune Shakes Up the Fantasy Genre!
- Now Shipping Epson ColorWorks CW-C8000 Color Label Printers Across the USA and Canada
- Purfresh Clean launches its new "SPACE" product - An innovative technology restaurants are using to get rid of their rat and mice problems